Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mydriatics for Posterior Synechia in Combined Surgery
NCT05614622Completed
- Sponsor
- Rabin Medical Center
- Start
- Nov 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of cyclopentolate in posterior synechiae (2 arms), sponsored by Rabin Medical Center. Primary endpoint: Number of participants developed iris posterior synechiae after surgery at 24 weeks. Started Nov 2020; status: completed.
02
Drugs
cyclopentolate
03
Conditions
posterior synechiae
Beyond the preview
Go deeper on NCT05614622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05614622.